33Y-16542-30714 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-08-20
Dose 1 — Pfizer-BioNTech
2021-09-10
Dose 2 — Pfizer-BioNTech
2021-09-14
Registered in v-safe
2021-09-14
Survey response — days 1–6 daily, dose 2
MedDRA: Chest pain, Palpitations — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities

Free text: Heart palpitations and chest pain

MedDRA releases: 2024-11 · check-in free text available
2021-09-15
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain

Adult check-in
2021-09-16
Survey response — days 1–6 daily, dose 2
MedDRA: Chest discomfort, Chest pain — Feeling: Fair · Muscle or body aches · Be unable to do your normal daily activities

Free text: Consistent chest pain and tightness for over 3 hours

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-08-20	Pfizer-BioNTech	No
2	2021-09-10	Pfizer-BioNTech	No

Free text

Release 9 — days 1–6 daily, dose 2

2021-09-14

Systemic reaction (other): Heart palpitations and chest pain

2021-09-16

Systemic reaction (other): Consistent chest pain and tightness for over 3 hours

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Chest discomfort	·	·	✓
SRO	Chest pain	·	·	✓
SRO	Palpitations	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release